Biotech Latest News

The Sedia™ HIV-1 Limiting Antigen Avidity Enzyme Immunoassay, a powerful new tool in the global fight against HIV, measures the maturation of the immune response to identify recent HIV infections among those already identified as positive.

Five New Doctors Begin Administering Proove Genetic Tests in Central and Southern Florida

International leaders to discuss today's issues from cell line selection to manufacturing. Summit to feature an expanded roster of meetings with increased formulation foci plus new meetings delving into early IND strategies and biomanufacturing.

Expanding the Array of Tools Available for Life Science Research

No-risk study build on next-generation software transfers risk away from sponsors and CROs

Acceliant, a global technology provider of innovative clinical solutions, is set to participate in 4th Annual Clinical Trials Summit to be held in Mumbai at Kohinoor Continental Hotel on 7th June, 2013.

New promise for separation in continuous flow chemistry reactions

Collaboration offers clients more streamlined and efficient approach to trial planning

Link Technologies to provide expertise during audience discussion at TIDES

Thermo Scientific iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates

The combination of Generis’s proven CARA user interface and NNIT’s leading implementation, validation and support services offer Life Sciences companies fast and easy access to new technology based on their existing Documentum platform.

Leading physicians to guide Paradigm’s molecular diagnostic testing to ensure quality and the best-in-class patient care.

TriLink BioTechnologies, Inc. (TriLink, trilinkbiotech.com) announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.

The 2013 Next Generation Dx Summit to bring together all of the major players in the evolving areas of diagnostics.

IT Infrastructure and the Cloud taking place May 28-29, 2013

Focusing on Clinical Genomics, NGS Data Analysis, Cancer Genomics

Cambridge Healthtech Institute announces the Molecular Medicine Tri-Conference Asia Conference – taking place at the Marina Bay Sands Hotel in Singapore May 28-31, 2013.

Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside.

Two Events in Singapore. One Location. May 28-31, 2013. Register Today!

Positive Revolution is a full service digital content marketing firm that focuses on generating sales and investor growth for emerging businesses.

Dr. Gerald Zon, noted scientist in the field of nucleic acid research launched a new blog in conjunction with TriLink Biotechnologies. The blog, Zone In with Zon (zon.trilinkbiotech.com), focuses on what's trending in the field of nucleic acids.

The Sedia™ HIV-1 Limiting Antigen Avidity Enzyme Immunoassay, a powerful new tool in the global fight against HIV, measures the maturation of the immune response to identify recent HIV infections among those already identified as positive.

Five New Doctors Begin Administering Proove Genetic Tests in Central and Southern Florida

International leaders to discuss today's issues from cell line selection to manufacturing. Summit to feature an expanded roster of meetings with increased formulation foci plus new meetings delving into early IND strategies and biomanufacturing.

The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy.

Researchers at the Ensminger Lab, University of Toronto, Canada, are using Tecan’s Infinite® M200 PRO plate reader and Gas Control Module (GCM™) to study host-pathogen interactions for Legionella bacteria.

Expanding the Array of Tools Available for Life Science Research

No-risk study build on next-generation software transfers risk away from sponsors and CROs

Acceliant, a global technology provider of innovative clinical solutions, is set to participate in 4th Annual Clinical Trials Summit to be held in Mumbai at Kohinoor Continental Hotel on 7th June, 2013.

New promise for separation in continuous flow chemistry reactions

Collaboration offers clients more streamlined and efficient approach to trial planning

Denali Allen, CPC joined Sanford Rose Associates® - San Diego team as a Principal in May of 2013.

Link Technologies to provide expertise during audience discussion at TIDES

Thermo Scientific iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates

The combination of Generis’s proven CARA user interface and NNIT’s leading implementation, validation and support services offer Life Sciences companies fast and easy access to new technology based on their existing Documentum platform.

Leading physicians to guide Paradigm’s molecular diagnostic testing to ensure quality and the best-in-class patient care.

TriLink BioTechnologies, Inc. (TriLink, trilinkbiotech.com) announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.

OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality...

Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.

The 2013 Next Generation Dx Summit to bring together all of the major players in the evolving areas of diagnostics.

Scientists at the specialised biotech company PharmAbcine are completing formulation and stability studies in a fraction of the time thanks to an Optim 1000 microvolume protein analysis and characterisation instrument from Avacta Analytical.

Custom system will ultimately enable DKMS Life Science Lab to type several thousand samples per week

Publication in Circulation Shows Genkyotex’s NOX Inhibitor Reduces Atherosclerosis Development

IT Infrastructure and the Cloud taking place May 28-29, 2013

Focusing on Clinical Genomics, NGS Data Analysis, Cancer Genomics

Cambridge Healthtech Institute announces the Molecular Medicine Tri-Conference Asia Conference – taking place at the Marina Bay Sands Hotel in Singapore May 28-31, 2013.

Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside.

Two Events in Singapore. One Location. May 28-31, 2013. Register Today!

Positive Revolution is a full service digital content marketing firm that focuses on generating sales and investor growth for emerging businesses.

BeeneGarter Survey on the Medical Device Excise Tax (MDET) open for month of May

Golden Helix, a leading bioinformatic software and services company, today announced the hiring of new President and CEO, Dr. Andreas Scherer, as the company seeks to expand its operations in the rapidly evolving field of translational genomics.

Outstanding Contribution to Skincare Innovation Award 2013 Intensifies As Hyderabad Pools More Votes than Delhi & Pune, Dr. Nilayini, Dr. Shuba Dharmana, Dr.Uday, Dr.Tripti Rathore, Dr. Lohiya at 4th Annual India Leadership Conclave & Awards 2013

Rheonix Inc, a molecular diagnostics device manufacturer based in Ithaca, New York, has integrated Tecan’s Cavro® Air Displacement Pipettor (ADP) into its EncompassMDx™ molecular platform.

AnaSpec is pleased to announce the recent release of two rabbit polyclonal antibodies. Anti-Tau antibody (GlcNAc Ser 400) recognizes the glycosylated [N-acetyl-D-glucosamine (GlcNAc)] Serine400 residue.

Visiongain predicts that the global market for ophthalmic drugs will reach $21.9bn in 2015. That market generated $17.5bn in 2011, according to Ophthalmic Drugs: World Market Prospects 2013-2023, published in March 2013.

Cell Culture Conference is to take place in London, UK, 3rd – 4th July 2013

Melstevia, Inc. announced today both Dr. Joseph Resnick and Dr. Ronald Stewart agreed to join MelStevia, Inc. as our new independent Science Team advisers.

An International Distributors Meeting was held on April 15th-16th, 2013 at the BioVision Facility in Milpitas, CA.

Extends the Company's Patent Estate for its Nano-Based LSPR Platform

Just released: final agenda. Hear the latest approaches to CTC capture and molecular profiling from 16 prominent scientists in 3 comprehensive sessions.

With rising development costs, increasing synthesis complexity, and lengthening regulatory processes, pharmaceutical companies are competing with what seems like ever-decreasing resources.

Delivering a state-of-the-art integrated computerized analysis instrument and cell enrichment solution

Immune Response BioPharma, Inc. to Seek Emergency Approval of REMUNE in Thailand & Begin Stockpiling HIV/AIDS Vaccine

Irwin Jacobs, Leonard Lavin, Ralph Rubio, Gene Ray among local entrepreneurs that star in film

New, expanded format includes 2 day and a half conferences presenting the points of view of all stakeholders involved in the process of companion diagnostic test design, manufacturing, clinical implementation and reimbursement.

Advanced electroporation systems for primary and iPSC-derived cells

Used In Pain Management Research and Drug Discovery, This Products Has Exciting Potential for Researchers

Greiner Bio-One is pleased to announce that based on a company focus on hard work and a dedication to safety, Greiner Bio-One North America, Inc. will receive the “Gold Level” Safety Award from the North Carolina Department of Labor for 2012.

Biotage has announced the launch of ISOLUTE® Myco SPE columns, a new product for the 'catch and release' clean up of mycotoxins from food matrices, prior to analysis by LC-MS/MS.

In partnership with the UC Berkeley Extension, Marble Arch Consultants, Inc. is pleased to present a learning opportunity for both business professionals and students.